ACTA1 and pulmonary fibrosis: Conversely, the inhibition of miR-21 in the mouse bleomycin model of pulmonary fibrosis prevented the increased expression of the fibrotic markers vimentin and smooth muscle actin (α-SMA) and attenuated EMT [84].